Cargando…
Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis
BACKGROUND AND OBJECTIVES: Long lasting immune response to anti-SARS-CoV-2 vaccination in people with Multiple Sclerosis (pwMS) is still largely unexplored. Our study aimed at evaluating the persistence of the elicited amount of neutralizing antibodies (Ab), their activity and T cell response after...
Autores principales: | Maglione, Alessandro, Francese, Rachele, Arduino, Irene, Rosso, Rachele, Matta, Manuela, Rolla, Simona, Lembo, David, Clerico, Marinella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318111/ https://www.ncbi.nlm.nih.gov/pubmed/37409134 http://dx.doi.org/10.3389/fimmu.2023.1205879 |
Ejemplares similares
-
Feeding the gut microbiome: impact on multiple sclerosis
por: Bronzini, Matteo, et al.
Publicado: (2023) -
Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies
por: Maglione, Alessandro, et al.
Publicado: (2022) -
Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
por: Maglione, Alessandro, et al.
Publicado: (2021) -
The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis
por: Rolla, Simona, et al.
Publicado: (2020) -
The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
por: Maglione, Alessandro, et al.
Publicado: (2019)